- Open Access
Parkinson’s disease-associated LRRK2-G2019S mutant acts through regulation of SERCA activity to control ER stress in astrocytes
Acta Neuropathologica Communications volume 7, Article number: 68 (2019)
Accumulating evidence indicates that endoplasmic reticulum (ER) stress is a common feature of Parkinson’s disease (PD) and further suggests that several PD-related genes are responsible for ER dysfunction. However, the underlying mechanisms are largely unknown. Here, we defined the mechanism by which LRRK2-G2019S (LRRK2-GS), a pathogenic mutation in the PD-associated gene LRRK2, accelerates ER stress and cell death. Treatment of cells with α-synuclein increased the expression of ER stress proteins and subsequent cell death in LRRK2-GS astrocytes. Intriguingly, we found that LRRK2-GS localizes to the ER membrane, where it interacts with sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) and suppress its activity by preventing displacement of phospholamban (PLN). LRRK2-GS–mediated SERCA malfunction leads to ER Ca2+ depletion, which induces the formation of mitochondria-ER contacts and subsequent Ca2+ overload in mitochondria, ultimately resulting in mitochondrial dysfunction. Collectively, our data suggest that, in astrocytes, LRRK2-GS impairs ER Ca2+ homeostasis, which determines cell survival, and as a result, could contribute to the development of PD.
Parkinson’s disease (PD), the second-most common neurodegenerative disease, is characterized by selective loss of dopaminergic (DA) neurons of the substantia nigra pars compacta (SNpc), accumulation of intracellular inclusions containing α-synuclein, and subsequent progressive impairment of dopaminergic neurons—the clinical feature of PD [6, 58]. It is mostly sporadic; less than 10% of PD cases are inherited . Despite intensive investigation, current treatments, medications, and even surgery do not cure or stop the progression of PD, highlighting the critical importance of understanding the mechanisms involved in the loss of dopaminergic neurons in PD. Recent studies suggested that non-neuronal cells, such as astrocytes, accumulate α-synuclein during PD, and can contribute to neurodegeneration through various pathways [7, 56], suggesting astrocytes play critical roles in neuronal dysfunction and interplays between astrocytes and neurons may provide insights into neuronal dysfunction and death in PD. However, relationship between astrocytic α-synucleintoxicity and neuronal dysfunction remains unclear.
Accumulating evidence from studies of the human PD brain suggest that the progressive deterioration of vulnerable SNpc DA neurons arises from cellular disturbances produced by misfolding and aggregation of the synaptic protein α-synuclein, disruption of the autophagy-lysosome system, mitochondrial dysfunction, and/or endoplasmic reticulum (ER) stress . The ER is the subcellular site of protein folding and maturation, and the main intracellular Ca2+ store of the cell. Since ER resident chaperones are involved in protein folding require high Ca2+ concentrations for their activity, altered ER Ca2+ homeostasis can result in an imbalance between the capacity of the protein processing machinery and the amount of unfolded proteins requiring processing, leading to an accumulation of unfolded proteins and ER stress [24, 30].
The increasing number of unfolded proteins inside the ER lumen provokes the dissociation of grp78/BiP (78 kDa glucose-regulated protein) from three ER transmembrane receptors—PKR-like endoplasmic reticulum kinase (PERK), activating transcription factor 6 (ATF6) and inositol-requiring enzyme 1 (IRE1)—thereby initiating the unfolded protein response (UPR). This ER-specific stress response serves to maintain cell survival through different molecular pathways, including reduced translation-initiation rate, enhanced protein folding, and/or elimination of misfolded proteins . Under conditions of prolonged or severe ER stress, however, the UPR switches from homeostatic feedback regulation towards proapoptotic signaling . Growing evidence from recent studies indicates that the accumulation of misfolded proteins in the brain is a salient feature of most neurodegenerative diseases, including Alzheimer’s disease, amyotrophic lateral sclerosis, Huntington’s disease, and PD . These diseases are now classified as protein misfolding disorders (PMDs) [13, 57]. The mechanisms leading to ER stress in PMDs and the actual impact of the UPR on the degeneration cascade in this disease are just starting to be uncovered.
A major genetic form of PD is caused by mutations in leucine-rich repeat kinase 2 protein (LRRK2) [37, 66]. The G2019S (GS) mutation within the kinase domain encoded by exon 41 is the most common mutation of LRRK2, which alters LRRK2 GTPase and kinase activities and accounts for ~ 1% of sporadic PD and up to 25% of familial PD in certain populations . The LRRK2 G2019S mutation causes a gain of function effect that could involve alterations in autophagy-lysosomal  and microRNA  pathways, and dysregulation of protein quality control [18, 32], oxidative stress [32, 49], and protein synthesis  mechanisms. Although the function of LRRK2 in ER stress remains a matter of debate, studies in Caenorhabditis elegans have demonstrated that expression of wild-type LRKK2 protects dopaminergic neurons against neurotoxicity induced by human α-synuclein through upregulation of grp78/BiP . Another study using a C. elegans model lacking the LRRK2 homolog suggested that LRRK2 is critical for preventing ER stress and spontaneous neurodegeneration . It has also been suggested that LRRK2 regulates anterograde ER-Golgi transport by anchoring Sec16A at ER exit sites, leading to a reduction in ER stress . Despite these interesting findings, the possible contribution of ER stress to the pathogenic manifestations of mutant LRKK2 in mammalian cells has not yet been addressed.
In this study, we showed that the LRRK2 G2019S mutant is responsible for ER stress in α-synuclein–treated brain astrocytes. Immunostaining and subcellular fractionation revealed that LRRK2-G2019S dissociates from 14 to 3-3 s and then localizes to the ER membrane. Using mass spectrometry (MS) proteomic screening of LRRK2-associated proteins, we identified sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) as a protein that strongly interacts with the LRRK2 G2019S mutant in the ER. Binding of LRRK2 G2019S to SERCA inactivated SERCA by maintaining the interaction of SERCA with phospholamban (PLN), which negatively regulates SERCA activity through direct association. The inactivation of SERCA by LRRK2 G2019S led to ER Ca2+ depletion, followed by chronic ER stress, mitochondria dysfunction, and cell death. Collectively, these findings indicate that LRRK2-G2019S accelerates ER stress, suggesting a molecular basis for the pathogenesis of PD in patients harboring this mutant.
Materials and methods
G2019S-LRRK2-Tg FVB mice were purchased from Jackson Laboratory (stock #009609, Bar Harbor, ME, USA). Non-Tg and G2019S-LRRK2-Tg heterozygous mice were prepared by crossing G2019S-LRRK2 heterozygous mice with wild-type mice. Genotyping was carried according to the vendor’s instructions. All animal procedures were approved by the Ajou University Institutional Animal Experimentation Committee (AMC-119).
Primary astrocytes were cultured from the cerebral cortices of 1-d-old non-Tg and G2019S-LRRK2-Tg heterozygous mice. Briefly, cortices were triturated into single cells in Dulbecco’s modified Eagle’s medium (DMEM; Sigma-Aldrich, St. Louis, MO, USA) containing 10% (v/v) fetal bovine serum (FBS; Hyclone, South Logan, UT, USA), plated into 75 cm2 T-flasks, and incubated for 2 wk. Following removal of microglia, primary astrocytes were enzymatically dissociated with trypsin (Sigma) for 5 min at 37 °C in a humidified 5% CO2, 95% air chamber. Trypsinization was quenched by adding astrocyte culture medium and centrifuged (~ 200 g) for 5 min. Microglia and meningeal cells were depleted by incubating astrocytes with serum-free DMEM for 2 d before use. The cell populations obtained consisted of more than 95% authentic astrocytes, as determined using the astrocyte marker GFAP (glial fibrillary acidic protein) immunofluorescence.
Primary neurons were cultured from embryonic mouse cortices (E17). Briefly, cortices were dissected in Hank’s Buffered Salt Solution (HBSS; Gibco, Carlsbad, CA, USA) supplemented with HEPES (10 mM, pH 7.4). Tissues were incubated in HBSS containing trypsin (Gibco) and DNase I (100 μg/ml) for 15 min at 37 °C, then dissociated by gentle pipetting. Dissociated cells were plated in poly-D-lysine (1 mg/ml)-coated 6-well plate (3 × 105 cells/well) or 12-mm cover glasses (1 × 104 cells) in Neurobasal medium containing B27 (2%), sodium pyruvate (1%), penicillin/streptomycin (1%), and GlutaMax (1%) (all supplements were from Gibco). Cells were incubated for 10 d and then challenged with α-synuclein for 24–48 h. For co-culture with astrocytes, cortical neurons were seeded on non-Tg or LRRK2-GS astrocyte monolayers for 10 d, then treated with α-synuclein for 24–48 h and assayed by immunocytochemistry.
C2 myoblasts were cultured as previously described . Briefly, cells were cultured in DMEM supplemented with 10% (v/v) FBS. Myogenic differentiation was induced by incubating in low-serum medium (DMEM plus 1% FBS) for 3 d. To induce ER stress, the astrocytes, neuron, and C2 myoblasts were incubated with vehicle or tunicamycin (0.1 μg/mL) (Sigma) for 3 ~ 24 h for each separate experiment.
Organotypic brain slice culture
Organotypic brain slice cultures were prepared from postnatal day 7–8 non-Tg and LRRK2-GS mice. Mice were anesthetized, and cortices were dissected and coronally sectioned (400 μm) using a McIlwain tissue chopper (Mickle Laboratory Engineering, UK). Slices were mounted on Millicell cell culture inserts (0.4 μm pore size, 30 mm diameter; Millipore, Burlington, MA, USA). Culture medium (50% minimal essential medium [MEM] containing 25% HBSS, 25% heat-inactivated horse serum, 0.5% glucose, 1 mM l-glutamine) was changed every 2–3 d. Slices were treated with α-synuclein or tunicamycin after 7 d in culture.
The human recombinant α-synuclein was purchased from rPeptide (Watkinsville, GA, USA) or was a kind gift from Professor Sang Myun Park (Ajou University, Korea). Purified recombinant α-synuclein protein was stored at − 80 °C until use as monomeric α-synuclein. The α-synuclein oligomer was prepared as previously described  with minor modifications. Briefly, 1 mg/ml of monomeric α-synuclein was dissolved in PBS (0.01 M sodium phosphate (pH 7.4), 150 mM NaCl), and incubated at 37 °C with continuous agitation at 250 rpm for 2 d, then stored at − 80 °C until use as oligomeric α-synuclein. Monomeric or oligomeric α-synuclein was mixed with 20 μM thioflavin T in 5x assay buffer (250 mM glycine, pH 8.5) in a final volume of 200 μl, and fluorescence was measured at 482 nm with excitation at 446 nm using a PerkinElmer Vitor3 multiplate reader (PerkinElmer, Waltham, MA, USA). Also, a 20 μl aliquot of α-synuclein was adsorbed onto carbon-coated copper grid and air-dried for 10 min. After negative staining with 2% uranyl acetate for another 10 min, α-synuclein was observed with an electron microscope (SIGMA500, Zeiss, Germany).
Plasmid DNA for C-terminal 3xMyc-tagged wild-type LRRK2, LRRK2-G2019S and LRRK2-D1994A, and FLAG-tagged LRRK2 fragments (L1–L4) were kind gifts from Professor Eun-hye Joe (Ajou University, Korea). Myc-tagged mouse SERCA was purchased from Origene (Rockville, MD, USA). pCMV-G-CEPIA1er was a gift from Masamitsu Iino (Addgene plasmid #58215); CMV-R-GECO1mito was a gift from Robert Campbell (Addgene plasmid #46021); pEF-myc-ER-E2-Crimson was a gift from Benjamin Glick (Addgene plasmid #38770); and mito-PAGFP was a gift from Richard Youle (Addgene plasmid #23348).
HEK293T cells were co-transfected with siRNA targeting the 3′-UTR region of LRRK2 and 3xMyc-tagged wild-type LRRK2 or G2019S-mutated LRRK2. After 24 h, cells were treated with α-synuclein for 24 h. ER, mitochondria, and MAM were isolated from HEK293T cells following the previously described protocols  with minor modifications. Briefly, HEK293T cells at ~ 90–100% confluence were harvested from 25 dishes (10 cm) and homogenized in isolation buffer (225 mM mannitol, 75 mM sucrose, 0.1 mM EGTA, 30 mM Tris-HCl pH 7.4) using a Dounce tissue grinder (Wheaton, Millville, NJ, USA). Nuclei and debris were removed by centrifuging the homogenate twice at 600×g for 10 min, after which the collected supernatant was centrifuged for 15 min at 8000×g. The resulting pellet was collected as the crude mitochondrial fraction. The supernatant was centrifuged at 20,000 g for 1 h, then again at 100,000 g for 1 h, after which the resulting pellet was resuspended as the ER fraction. The supernatant was kept as the cytosolic fraction. For pure mitochondria and MAM fractions, the crude mitochondrial pellet was resuspended in 2 ml mitochondrial resuspension buffer (MRB; 250 mM mannitol, 5 mM HEPES pH 7.4, 0.5 mM EGTA), layered over 30% Percoll medium in a centrifuge tube, and centrifuged at 95,000×g for 30 min. The lower layer (pure mitochondria) and intermediate layer (MAM) between the light membrane and pure mitochondria fractions were then collected. The pure mitochondria fraction was diluted in MRB buffer and further centrifuged at 10,000 g, after which the pellet was resuspended in 300 μl of MRB buffer. The MAM fraction was diluted 10x in MRB buffer and centrifuged at 100,000×g for 1 h, after which the pellet was resuspended in a small volume of MRB buffer.
Time-lapse Ca2+ imaging
Astrocytes isolated from non-Tg or LRRK2-GS mice were plated on glass-bottom dishes (Nest Scientific, China) and then treated with α-synuclein or tunicamycin (0.1 μg/ml) for 24 h. ER Ca2+ release into the cytosol was measured in cells loaded with 5 μM Fluo4-AM (Invitrogen, Carlsbad, CA, USA) in HBSS containing 0.05% Pluronic F-127 (Thermo Fisher Scientific, Waltham, MA, USA) at 37 °C. After 20 min, excess Fluo4-AM was removed by washing cells twice, and then the wash buffer was replaced with HBSS without Ca2+ and Mg2+. Cells were stimulated with 500 μM histamine (Sigma) and imaged under a confocal microscope (TCS, DMi8; Leica, Germany) equipped with a 40x objective (NA 1.10) in a chamber with temperature and CO2 control and a heated stage (LCI, Korea). Images were captured at a rate of one frame per 1 or 2 s. For evaluate Ca2+ dynamics in ER and mitochondria, transfection was performed by incubating astrocytes with a mixture of 1 μg of G-CEPIA1er and R-GECO1mito, Lipofectamine 2000 (Life Technologies) for 5 h. After incubation, the medium was changed and the cells were incubated at 37 °C in 5% CO2. After 24 h, the medium was replaced with HBSS without Ca2+ and Mg2+, and then cells were stimulated with histamine and imaged with a confocal microscope equipped with a 40x objective (NA 1.10). Images were captured at a rate of one frame per 1 or 2 s with the following excitation/emission spectra: G-CEPIA1er, 488 nm/500–550 nm; R-GECO1mito, 552 nm/560–800 nm. After all Ca2+ intensities were corrected for background subtraction, ΔF values were calculated from (F–F0). F0 values, used for normalization, were defined by averaging 10 frames before stimulation.
Immunoprecipitation and nanoLC-MS/MS
HEK293T cells were co-transfected with siRNA targeting the 3′-UTR region of LRRK2 and 3xMyc-tagged wild-type LRRK2 or G2019S-mutated LRRK2. After 24 h, cells were treated with α-synuclein for 24 h and then lysates were prepared using a modified RIPA buffer. Lysates (1 mg) were immunoprecipitated with anti-Myc antibody-conjugated magnetic beads (Invitrogen). Immunoprecipitated proteins were digested with trypsin and quantified on a nanoLC-MS/MS platform. The raw MS files were analyzed and searched against a human protein database based on the species of the sample using Proteome Discoverer 2.0 (Thermo Fisher Scientific). The parameters were set as follows: protein modifications, carbamidomethylation (C) (fixed) and oxidation (M) (variable); enzyme specificity, trypsin; maximum missed cleavages, 2; precursor ion mass tolerance, 10 ppm; and MS/MS tolerance, 0.6 Da. To ensure high confidence identifications, peptide-to-spectrum match (PSM), peptides, and proteins were filtered at a less than 1% false discovery rate (FDR). Three independent replicates for each experimental condition were carried out to control for intrasample variation. In total, 2831 proteins were identified for this project, and were divided into two categories of relative quantitation. Those with a quantitative ratio greater than 1.5 were considered up-regulated, whereas those with a quantitative ratio less than 0.67 were considered down-regulated (Creative Proteomics, Shirley, NY, USA). Protein interactions identified in this study have been submitted to the IMEx (http://www.imexconsortium.org) consortium through IntAct  and assigned the identifier IM-26684.
Cytoscape analysis of LRRK2-interacting proteins
LRRK2-interacting proteins identified by nanoLC-MS/MS were analyzed using the ClueGo Cytoscape plugin with Cellular Component and Biological Process function Gene Ontology annotations. The groups consist of nodes (cellular component) connected to reflect functional relationships between nodes. Each functional group is annotated in colored type.
Analysis of mitochondrial morphology
For visualization of mitochondria, cells were stained with 250 nM MitoTracker Red CMXRos (Invitrogen) for 20 min at 37 °C. Mitochondrial morphology subtypes were quantified using an automated classification system, according to Peng et al. . After semi-automated segmentation of cell micrographs, mitochondria were classified into six distinct subtypes—small globe, swollen globe, straight tubule, twisting tubule, branch tubule and loop—using automated classification software. The proportion of tubular mitochondria was calculated by totaling straight tubule, twisting tubule, and branch tubule mitochondrial populations. The proportion of fragmented tubular mitochondria was calculated based on small globe mitochondrial populations. High-powered (400 x) fields of micrographs from three independent areas per group were analyzed, and about 200–300 mitochondria from 5 cells were used in calculations.
Tetramethylrhodamine methyl ester imaging
For tetramethylrhodamine methyl ester (TMRM) imaging, astrocytes isolated from non-Tg or LRRK2-GS mice were plated on glass-bottom dishes (Nest Scientific), and then treated with α-synuclein. After 24 h, the medium was replaced with HBSS supplemented with 10 nM TMRM (Invitrogen), and cells were incubated for 30 min at 37 °C. Cells were imaged with a confocal microscope (TCS, DMi8, Leica) equipped with a 40x objective (1.10 NA) in a chamber with temperature and CO2 control and a heated stage. Mitochondrial membrane potential was dissipated by treating cells with 10 μM carbonyl cyanide m-chlorophenyl hydrazone (CCCP; Sigma).
Astrocytes isolated from non-Tg and LRRK2-GS mice were treated with α-synuclein for 24–48 h and then stained with the superoxide indicator, MitoSOX Red (5 μM; Invitrogen), for 30 min at 37 °C. Cells were treated with trypsin and analyzed by flow cytometry using a FACS Canto II flow cytometer (BD Biosciences, San Jose, CA, USA).
Astrocytes isolated from non-Tg and LRRK2-GS mice were treated with α-synuclein for 24 h and then fixed with 4% paraformaldehyde and then permeabilized with 0.25% triton for 10 min. Cells were washed three times in PBS and blocked with 1% BSA for 1 h. Cells were incubated with primary antibodies overnight at 4 °C. Washed cells were incubated with fluorescent secondary antibody (Invitrogen) for 1 h at room temperature. Cover slips were mounted with Vectashield containing DAPI (Vector Laboratories) and viewed on confocal microscope confocal microscope (TCS, DMi8; Leica).
TUNEL assays were carried out using a commercial kit according to the manufacturer’s instructions (Invitrogen). Briefly, cells and proteinase K-treated organotypic slices were rinsed with phosphate-buffered saline (PBS), and then incubated in 1x equilibration buffer for 10 min. Thereafter, samples were incubated with terminal deoxynucleotidyl transferase (TdT) for 1 h at 37 °C, blocked with stop/wash buffer, and incubated with peroxidase antibody for 30 min at room temperature. The images were taken from layer 1 of the cortex in brain slices (n = 5 slices from 3 mouse) and the percentage of TUNEL-positive cells was determined in at least 10 optical fields.
Proximity ligation assay (PLA)
Fixed cells were stained with the indicated rabbit and mouse antibodies. Duolink-PLA (Olink Bioscience, Sweden) procedures were performed according to the manufacturer’s instructions. Each discrete red spot represents a protein-protein complex (radius < 40 nm).
Proteinase protection assay
ER-enriched fractions from non-Tg and LRRK2-GS astrocytes were prepared using the method described above (refer to Subcellular fractionation). For proteinase protection assays, ER-enriched fractions were diluted in homogenization buffer at a protein concentration of 0.5 μg/μl and incubated in the absence or presence of 150 μg/ml Proteinase K (Invitrogen) for 30 min. The reaction was terminated by adding phenylmethylsulfonyl fluoride (PMSF) to a final concentration of 5 mM and incubating on ice for 5 min. Subsequently, an equal volume of 2x SDS sample buffer was added and protein in the samples was denatured by incubation at 100 °C for 5 min. For Western blot analysis, samples were resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS/PAGE). Digestion was monitored using endogenous calnexin and BiP as controls.
Synthesis and transfection of siRNA
siRNA duplex oligonucleotides were chemically synthesized by Bioneer (Daejeon, Korea) and Santa Cruz (Santa Cruz, CA). Details of the siRNA sequences are described in Additional file 2: Table S2. Confluent astrocytes were transfected with siRNA oligonucleotides (50 μM) using Lipofectamine RNAiMax reagent (Invitrogen) according to the manufacturer’s instructions. All assays were performed at least 48 h after RNAi transfection.
Cells were lysed with RIPA buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS, 2 mM EDTA pH 8.0) supplemented with a protease inhibitor cocktail (GenDEPOT, Barker, TX, USA) at 4 °C for 30 min. Samples were separated by SDS-PAGE and transferred to nitrocellulose membranes. Membranes were incubated with primary antibodies (Additional file 2: Table S4) and horseradish peroxidase (HRP)-conjugated secondary antibodies, and immunoreactive proteins were visualized using an enhanced chemiluminescence system (Ab Frontier, Seoul, Korea).
Real time quantitative reverse transcription-polymerase chain reaction (RT-qPCR) analysis
Total RNA was isolated using RNAiso Plus (TaKaRa, Japan), and cDNA was synthesized using avian myeloblastosis virus reverse transcriptase (New England Biolabs, Ipswich, MA, USA) and oligo (dT) primers (Promega, Madison, WI, USA), according to the manufacturers’ instructions. For qPCR, amplification reactions were performed using a Thermal Cycler Dice Real-Time System (TaKaRa) with SYBR Premix Ex Taq master mix (TaKaRa) according to the manufacturer’s instructions. The primers used for qPCR (Bioneer) are described in Additional file 2: Table S3.
The significance of differences between groups was determined using Student’s t-test. A p-value of 0.05 was considered significant. Values are presented as means ± standard deviation (SD).
α-Synuclein induces ER stress and cell death in LRRK2-G2019S astrocytes
Prolonged ER stress stimuli are associated with sustained activation of the UPR pathway and its switch to proapoptotic signaling. Of particular importance is the PERK pathway, which is involved inducing activating transcription factor 4 (ATF4), thereby controlling the expression of genes involved in cell death pathways, including CCAAT/enhancer-binding protein homologous protein (CHOP) . Thus, we first assessed the severity of ER stress in astrocytes from LRRK2-G2019S mutant (LRRK2-GS-Tg) mice compared with those from non-transgenic (non-Tg) mice. To this end, we challenged non-Tg and LRRK2-GS astrocytes with monomeric or oligomeric α-synuclein for 24 h. Oligomeric α-synuclein incubated 2 days were used for experiments (Additional file 2: Figure S1a-b). We found that both types of α-synuclein induced apoptotic PERK-CHOP signaling in LRRK2-GS astrocytes, as evidenced by increases in mRNA and protein levels of the ER stress markers (Fig. 1 a-b). Since it is known that α-synuclein oligomers are more toxic conformation in PD, we choose oligomeric form of synuclein (0.5 μM) to induce ER stress in all experiments, though the monomeric and oligomeric α-synuclein have similar effect on ER stress response. To define the biological consequences of ER stress in LRRK2-GS astrocytes, we treated non-Tg and LRRK2-GS astrocytes with α-synuclein and quantified apoptotic cells using terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assays. Apoptotic cells were frequent following treatment of LRRK2-GS astrocytes with α-synuclein, but were scarce among α-synuclein–treated non-Tg astrocytes (Fig. 1c). Small interfering RNA (siRNA)-mediated knockdown of CHOP markedly reduced the number of TUNEL-positive cells, suggesting that increased cell death in LRRK2-GS astrocytes is caused by severe ER stress. To further extend these findings, we tested whether similar events occurred under ex vivo conditions using brain slices obtained from non-Tg and LRRK2-GS mice. Compared with slices from non-Tg brains, LRRK2-GS brain slice cultures showed marked expression of ER stress-related proteins (Fig. 1d) and an increase in TUNEL/CHOP-positive astrocytes (Fig. 1e). Similar results were obtained following challenge with the ER-stress–inducing agent, tunicamycin (Additional file 2: Figure S1 c–f). Taken together, these results show that ER-stress–mediated cell death is significantly increased in LRRK2-GS astrocytes after α-synuclein treatment.
G2019S-mutated LRRK2 is localized to the ER through disruption of 14–3-3 s binding
To study the underlying mechanism by which LRRK2-GS causes ER stress, we first determined whether LRRK2 is localized to the ER. To this end, we performed co-immunostaining of endogenous LRRK2 and calnexin, an ER membrane protein. Some overlap between the two proteins was found in α-synuclein treated non-Tg astrocytes, but most signals appeared as neighboring, but not colocalized, speckles scattered around the cytoplasm. In LRRK2-GS astrocytes, however, α-synuclein treatment caused greater ER targeting of LRRK2 to the ER in LRRK2-GS astrocytes than in non-Tg astrocytes (Fig. 2a and Additional file 2: Figure S2a). To confirm the precise location of LRRK2 within the ER, we performed a membrane proteinase “shaving” assay on LRRK2-GS and non-Tg astrocytes using an ER-enriched fraction. Briefly, ER-enriched fractions were first incubated with proteinase K (PK), after which the digestion products were analyzed for immunoreactivity with antibodies specific for the N- or C-terminal region of LRRK2 (N138/6 and N241A/34, respectively). Parallel immunoblots of the same lysates with anti-LRRK2 antibodies revealed a loss of immunoreactivity to both N- and C-terminal LRRK2 antibodies following PK treatment, indicating that LRRK2-GS was mainly bound to the cytosolic side of the ER membrane, rather than being localized within the ER (Fig. 2b and Additional file 2: Figure S2b). These results indicate greater localization of LRRK2 to the ER in LRRK2-GS astrocytes than in non-Tg astrocytes and suggest involvement of LRRK2-GS function in ER stress at the cytosolic side of the ER.
Previous reports have indicated that 14–3-3 proteins, a family of seven conserved adapter proteins, are involved in the localization of LRRK2 [9, 33]. 14–3-3 proteins bind to target proteins and modulate their activity, stability and/or subcellular localization; they also participate in many cellular functions, playing an important role in cell survival . Recent reports have demonstrated that 14–3-3 s binding to LRRK2 is disrupted in some PD-related LRRK2 mutations, influencing its localization in the cell [21, 33]. Because we found that LRRK2-GS showed greater ER localization, we hypothesized that the interaction of 14–3-3 proteins with LRRK2 is altered in LRRK2-GS astrocytes. To test this, we performed co-immunoprecipitation of LRRK2 and various 14–3-3 isoforms using whole-cell lysates of LRRK2-GS and non-Tg astrocyte. We found that, although all six isoforms of 14–3-3 bound LRRK2, the γ and η isoforms showed diminished association with LRRK2 in LRRK2-GS astrocytes compared with non-Tg astrocytes (Fig. 2c and Additional file 2: Figure S2c). To verify the role of 14–3-3 s in LRRK2-GS localization, we measured LRRK2 protein levels in the ER-enriched fraction from astrocytes transfected with siRNA targeting individual 14–3-3 s subtypes. These experiments revealed that ER localization of LRRK2-GS was increased in cells in which the γ, or η isoform of 14–3-3 was knocked down (Fig. 2d). These results indicate that 14–3-3 proteins are involved in the localization of LRRK2 to ER, although the precise mechanism remains to be clarified.
LRRK2-GS interacts with SERCA
Next, in an effort to identify LRRK2-interacting proteins in the ER membrane, we performed label-free MS analyses of proteins co-immunoprecipitated with LRRK2 in α-synuclein–treated HEK293T cells transiently transfected with either Myc-tagged human wild-type LRRK2 (Myc-LRRK2-WT) or LRRK2-G2019S (Myc-LRRK2-GS). In total, 2831 proteins were identified, 232 of which showed increased interaction in LRRK2-GS–transfected cells compared with LRRK2-WT–transfected cells (Additional file 1: Table S1). A Cytoscape network analysis revealed that LRRK2-GS–interacting proteins could be categorized into five major groups according to Cellular Component: endoplasmic reticulum, proteasome complex, ribosomal subunit, ficolin-1 rich granule, and mitochondrial protein complex (Additional file 2: Figure S3a). A Biological Process gene ontology (GO) analysis further revealed that LRRK2-GS is involved in ER stress or UPR (Fig. 3a and Additional file 2: Figure S3b). To determine which of these ER-component proteins directly interacted with LRRK2-GS, we immunoprecipitated lysates of α-synuclein–treated non-Tg or LRRK2-GS astrocytes using antibodies against LRRK2 and then identified individual LRRK2-associated proteins in immunoprecipitates. Notable among these LRRK2-GS–interacting proteins was SERCA2/ATP2A2, an ER Ca2+ ATPase responsible for regulating Ca2+ transport across the ER membrane (Additional file 2: Figure S4a and Figure 3b). Enhanced LRRK2–SERCA2 interactions in LRRK2-GS astrocytes were further confirmed using proximity ligation assays (PLA) (Fig. 3c). Control experiments using the ER-stress–inducing agent tunicamycin instead of α-synuclein revealed prominent SERCA binding to LRRK2 (Additional file 2: Figure S4b).
To gain further molecular insights into LRRK2–SERCA interactions, we transfected HEK293T cells with full-length Myc-tagged SERCA and Flag-tagged, truncated mutants of LRRK2, and analyzed SERCA–LRRK2 binding by immunoprecipitation and Western blotting. These analyses showed that leucine-rich repeat (LRR) and carboxy-terminal of Roc (COR) domains of LRRK2 interacted with SERCA (Fig. 3d). These results are consistent with previous reports that LRR and COR domains participate in protein-protein and intramolecular interactions [14, 51], and collectively confirm that LRRK2 and SERCA directly bind each other through LRRK2 LRR and COR domains.
Because we found that 14–3-3 s are involved in ER localization of LRRK2-GS (Fig. 2), we tested whether 14–3-3 s affects LRRK2-GS–SERCA interactions. As expected, LRRK2-GS–SERCA interactions were increased by siRNA-mediated knockdown of γ and η forms of 14–3-3 s compared with that observed in the si-control–transfected LRRK2-GS group (Additional file 2: Figure S4 c-d). These results indicate that LRRK2-GS freed from 14 to 3-3 s localizes to the ER and interacts with SERCA.
LRRK2-GS promotes ER Ca2+ depletion by maintaining SERCA–PLN interactions
Because LRRK2-GS is co-localized and physically associated with SERCA, we examined whether Ca2+ flux is altered in LRRK2-GS astrocytes using the fluorescent cytosolic Ca2+ indicator dye, Fluo4-AM. To this end, we pretreated LRRK2-GS and non-Tg astrocytes with α-synuclein for 24 h, loaded cells with Fluo4-AM. Cells were then stimulated with histamine, which generates cytosolic Ca2+ oscillations by inducing Ca2+ release from the ER via inositol 1,4,5-trisphosphate receptors (IP3Rs). Following stimulation with histamine, the peak amplitude of Ca2+ bursts was decreased in LRRK2-GS astrocytes compared with that in non-Tg astrocytes, reflecting ER Ca2+ store depletion by α-synuclein treatment. Moreover, the duration of Ca2+ bursts was longer owing to malfunction of SERCA in LRRK2-GS astrocytes (Fig. 4 a-b; Online Resource 1 and 2). To further confirm this, we determined ER Ca2+ dynamics using G-CEPIA1er (calcium-measuring organelle-entrapped protein indicator 1 in the ER), a genetically encoded, GFP-tagged ER Ca2+ indicator. In non-Tg astrocytes, stimulation of astrocytes with histamine induced depletion of ER Ca2+ followed by recovery toward the pre-stimulation level. In LRRK2-GS astrocytes, however, fluorescence intensity was reduced and ER Ca2+ refilling was blocked. Measurements of ER Ca2+ recovery rate showed that ER Ca2+ was scarcely reloaded in LRRK2-GS astrocytes, but was readily reloaded in non-Tg astrocytes (Fig. 4 c-d; Online Resource 3 and 4). These results suggest that LRRK2–SERCA interactions in LRRK2-GS astrocytes cause malfunction of SERCA, resulting in ER Ca2+ depletion, and possibly increased ER stress-induced cell death.
SERCA activity is mediated in various ways. A recent study reported that small-conductance Ca2+-activated potassium (SK) channels are present in the ER of cardiomyocytes and neurons, where they regulate ER Ca2+ uptake and protect against ER-stress–induced cell death . We therefore investigated the effects of SK channel activation in our model of ER stress-induced cell death. For this, we applied cyclohexyl-[2-(3,5-dimethyl-pyrazol-1-yl)-6-methyl-pyrimidin-4-yl]-amine (CyPPA), a positive modulator of SK channels that is selective for SK2 and SK3 subtypes. However, application of CyPPA did not protect against α-synuclein–induced ER stress in LRRK2-GS astrocytes, indicating that SK2 and SK3 channels are not involved in LRRK2-GS–mediated SERCA inactivation (Additional file 2: Figure S5a). It has also been reported that SERCA activity is regulated by the ER protein chaperones, calreticulin (CRT), calnexin (CLNX), and ER protein 57 (ERp57). Although the precise molecular mechanism is not completely known, CRT and CLNX can regulate SERCA directly or possibly indirectly by recruiting other enzymes, such as ERp57 [46, 62]. To determine whether these chaperones are involved in SERCA inactivation, we performed co-immunoprecipitation assays in non-Tg and LRRK2-GS astrocytes using antibodies against SERCA and individual chaperone proteins. However, we found no significant difference in SERCA-chaperone interactions between non-Tg and LRRK2-GS astrocytes. Some studies have suggested that redox-sensitive selenoprotein N (SEPN1) and thioredoxin-related transmembrane protein 1 (TMX1) bind to loop 4 cysteines in SERCA and regulate ER Ca2+ uptake activity [27, 42]. But we found that these potential regulators also showed no difference in their interactions with SERCA between non-Tg and LRRK2-GS astrocytes (Additional file 2: Figure S5b). Finally, we explored the involvement of the small transmembrane protein PLN, which decreases ER Ca2+ uptake through association with SERCA. Protein kinase A (PKA)-mediated phosphorylation of PLN causes PLN dissociation from SERCA, permitting near-maximal Ca2+-ATPase activity and increased ER Ca2+ loading in cardiac and skeletal muscle . Although it is known that PLN is expressed almost exclusively in muscle cells, we confirmed expression of PLN protein in astrocytes, but not neurons (Additional file 2: Figure S5c). We then co-immunoprecipitated SERCA and PLN from lysates of non-Tg and LRRK2-GS astrocytes. These analyses showed that SERCA–PLN interactions were increased in LRRK2-GS astrocytes compared with non-Tg astrocytes (Fig. 4e), suggesting that LRRK2-GS–SERCA interactions inhibit dissociation of PLN from SERCA. Taken together, these findings suggest that LRRK2-GS mediates SERCA inactivation through maintenance of PLN–SERCA interactions, thereby leading to continued ER Ca2+ depletion.
LRRK2-GS increases ER-mitochondrial contact and leads to mitochondrial Ca2+ overload and dysfunction
In addition to distinct and independent roles of the ER and mitochondria, accumulating recent evidence suggests that the two organelles physically and functionally interact at sites designated mitochondria-associated ER membranes (MAMs) . MAMs have a key regulatory role in various cellular functions, including the transfer of Ca2+ and lipids from the ER to mitochondria, regulation of mitochondrial dynamics, and formation of signaling scaffolding . These ER contact sites are enriched in specific proteins, such as IP3R Ca2+ channels; the mitochondrial-ER tethering proteins, mitofusin-2 (Mfn2) and phosphofurin acidic cluster sorting protein 2 (PACS2); and chaperones, such as sigma 1 receptor (Sig1R) and CLNX. Accordingly, dysfunctions in one organelle can affect the other, leading to various pathologies, including neurodegenerative diseases [36, 48]. Under conditions of cell stress, particularly ER stress, the extent of MAMs and magnitude of Ca2+ flux from the ER to mitochondria increases, producing considerable amounts of reactive oxygen species (ROS) and inducing opening of the mitochondrial permeability transition pore (mPTP), promoting proapoptotic signaling . Because we found that interactions of LRRK2-GS with SERCA disrupt Ca2+ homeostasis and increase ER stress, we sought to verify ER-to-mitochondrial function in non-Tg and LRRK2-GS astrocytes. First, to investigate ER-mitochondrial interactions, we co-expressed mitochondria-targeted GFP (mito-GFP) and ER-targeted E2-Crimson (ER-Crimson) in non-Tg and LRRK2-GS astrocytes and imaged cells by fluorescence microscopy. The proportion of ER and mitochondria colocalization in LRRK2-GS astrocytes was greater than that in non-Tg astrocytes (Fig. 5a). Transmission electron microscopy (TEM) images further revealed that the proportion of the ER in close contact with mitochondria was higher in LRRK2-GS astrocytes than non-Tg astrocytes (Fig. 5b). To confirm these results, we performed Percoll-based subcellular fractionation of HEK293T cells transfected with Myc-LRRK2-WT or Myc-LRRK2-GS, and collected fractions enriched for mitochondria, the ER, or MAM. IP3R and CLNX were preferentially found in ER fractions, whereas cytochrome C and Mfn2 were enriched in mitochondrial fractions, results in line with previous reports . Interestingly, the levels of IP3R, CLNX and Mfn2 in MAM fractions were higher in Myc-LRRK2-GS–transfected cells than in Myc-LRRK2-WT–transfected cells (Fig. 5c), suggesting a possible redistribution of these proteins from the ER or mitochondrial membrane to MAMs. Taken together, these results indicate that ER-mitochondria contact sites are increased in LRRK2-GS astrocytes.
The fact that LRRK2-GS disrupts Ca2+ homeostasis in the ER by interacting with SERCA (Figs. 3 and 4), taken together with the increase in Ca2+ regulatory proteins in MAMs of LRRK2-GS astrocytes, led us to postulate that Ca2+ flux from the ER to mitochondria is increased in LRRK2-GS astrocytes, with deleterious effect on mitochondrial functions. To address this possibility, we assessed ER and mitochondria Ca2+ dynamics by expressing G-CEPIA1er or R-GECO1mito, indicators of ER and mitochondria Ca2+, respectively, in non-Tg and LRRK2-GS astrocytes. In non-Tg astrocytes, histamine stimulation induced depletion of ER Ca2+, with subsequent recovery of ER Ca2+ to pre-stimulation levels. Despite these changes in ER Ca2+, mitochondrial Ca2+ levels were largely unchanged (Fig. 5 d a-f; Online Resource 5). In contrast to non-Tg astrocytes, LRRK2-GS astrocytes exhibited ER Ca2+ depletion and a burst in elevated mitochondrial Ca2+ uptake (Fig. 5 e-g; Online Resource 6), suggesting that Ca2+ flux from the ER to mitochondria was increased in LRRK2-GS astrocytes. Next, we determine whether mitochondrial Ca2+ overload was accompanied by mitochondrial dysfunction. First, we examined morphological changes in mitochondria in non-Tg and LRRK2-GS astrocytes. To this end, we stained cells with MitoTracker and assigned mitochondria to one of two categories: tubular or fragmented. The number of LRRK2-GS astrocytes containing fragmented mitochondria was increased compared with non-Tg astrocytes (Fig. 5 h-i). We also found that mitochondrial membrane potential was lower (Fig. 5j) and mitochondrial ROS levels were higher (Fig. 5k) in LRRK2-GS astrocytes, as measured by tetramethyl rhodamine methyl ester (TMRM) and MitoSOX fluorescence, respectively. These data, taken together with the altered mitochondrial morphology observed in LRRK2-GS astrocytes, demonstrate that high Ca2+ flux from the ER to mitochondria, caused by LRRK2-GS–mediated SERCA inactivation, is associated with mitochondrial dysfunction.
LRRK2 kinase activity is not required for LRRK2 localization to the ER
It is well known that the LRRK2-GS mutation in the kinase domain leads to increase in catalytic activity, a change that underlies the neurotoxic effect of this mutant [12, 55]. Moreover, treatment with LRRK2 kinase inhibitors mitigates toxicity and neurodegeneration both in vitro and in vivo [5, 20]. However, there are conflicting reports regarding the role of LRRK2 kinase activity in ER dysfunction and cell death. Yuan and colleagues reported that LRRK2-GS causes cell death through chronic p38 activation in an LRRK2 kinase-dependent manner , whereas another study suggested that LRRK2 kinase activity may not regulate the interaction of Sec16A with LRRK2, which leads to ER-Golgi transport dysfunction . Our fractionation experiments showed that α-synuclein–induced ER translocation of LRRK2 was not suppressed by treatment with the LRRK2 kinase inhibitors, IN-1 or PF-06447475 (Additional file 2: Figure S6a), suggesting that this translocation is independent of LRRK2 kinase activity. In line with ER fractionation assays, immunoprecipitation experiments further showed that LRRK2-SERCA interactions were not significantly changed by treatment with either kinase inhibitor (Additional file 2: Figure S6b, upper panel). Contrary to our expectation, however, expression of ER stress and cell death marker proteins were suppressed by both inhibitors (Additional file 2: Figure S6b, lower panel; Additional file 2: Figure S6c). These findings suggest that LRRK2-GS causes ER stress through a mechanism that involves LRRK2 kinase activity-independent SERCA inactivation, or another pathway that is affected by enhanced LRRK2 kinase activity.
LRRK2-GS astrocytes cause death of cortical neurons
Because astrocytes secrete a range of factors, including neurotrophic factors, growth factors and cytokines that stimulate remyelination by promoting neuronal survival, neurite outgrowth and neurogenesis, astrocyte dysfunction might drive neuronal disease . In this context, death of LRRK2-GS astrocytes owing to ER stress could aggravate neuronal damage and death. To address whether LRRK2-GS astrocytes are involved in the dysfunction and loss of cortical neurons, we used a coculture system in which non-Tg or LRRK2-GS cortical neurons were directly plated onto a feeder layer of non-Tg or LRRK2-GS astrocytes (Additional file 2: Figure S7a). In non-Tg as well as LRRK2-GS neuron plated on LRRK2-GS astrocytes, α-synuclein treatment decreased expression of the neuron-specific class III beta-tubulin (Tuj1) and neurite length, supporting the concept that ER stress-induced death of LRRK2-GS astrocytes aggravates neuronal damage (Fig. 6 a–c). In a complementary approach, we collected astrocyte-conditioned medium (ACM) from non-Tg or LRRK2-GS astrocytes and applied it to primary cortical neurons (Additional file 2: Figure S7b). We found that treatment of neurons with ACM from LRRK2-GS astrocytes decreased neurite length and the percentage of cells positive for microtubule-associated protein 2 (MAP2), a marker for differentiated neurons, compared with treatment with ACM from non-Tg astrocytes (Additional file 2: Figure S7 c-d). Moreover, the percentage of MAP2+ neurons was sharply reduced in brain slices from LRRK2-GS mice, in association with an increase in TUNEL-positive cells, compared with non-Tg brain slices (Fig. 6 d-f). Previous studies have shown that a transgenic mouse model in which human LRRK2-GS is overexpressed exhibits a modest loss of dopaminergic neurons accompanied by accumulation of autophagosomes, mitochondrial alterations and ER stress, revealing direct toxic effect of LRRK2-GS on neurons [41, 65]. In our study, however, we found no difference in SERCA–LRRK2 interactions, expression of ER stress proteins, or cell death between non-Tg and GS neurons. Moreover, PLN is not expressed in neurons (Additional file 2: Figure S7e), as previously reported . These results suggest that the functions of LRRK2-GS in neurons and astrocytes differ with respect to ER stress. Specifically, neuronal damage and death in LRRK2-GS mice reflect the effects of abnormal astrocytes, rather than a direct effect of LRRK2-GS on neurons.
LRRK2-GS is also involved in enhanced ER stress in other cell types
The role of SERCA in refilling intracellular Ca2+ stores is pivotal for maintaining intracellular Ca2+ homeostasis. Accordingly, disturbed SERCA activity is involved in a variety of diseases, including heart failure, diabetes, cancer, and Alzheimer’s disease . The importance of the SERCA pump in cardiac and skeletal muscle function, in particular, has been extensively studied. . Because we showed that LRRK2-GS promotes Ca2+ dyshomeostasis by maintaining SERCA–PLN interactions, we explored whether the effect of LRRK2-GS on SERCA inactivation was general or astrocyte specific. To this end, we expressed Myc-LRRK2-WT or Myc-LRRK2-GS in C2 myoblasts, a skeletal muscle cell line, and treated them with tunicamycin. We found that pro-apoptotic PERK-CHOP signaling was increased in LRRK2-GS–expressing C2 cells, as determined by an assessment of mRNA and protein expression of the ER stress markers by qRT-PCR and Western blotting, respectively (Fig. 7 a-b). Moreover, SERCA–LRRK2 interactions were increased in LRRK2-GS–expressing C2 cells compared with LRRK2-WT–expressing cells (Fig. 7b). Enhanced LRRK2–SERCA interactions in LRRK2-GS–expressing C2 cells were further confirmed using the PLA method (Fig. 7c). To determine whether the increase in LRRK2–SERCA interactions in LRRK2-GS–expressing C2 cells subsequently affects ER stress responses, we determined whether Ca2+ flux was altered in this alternative cell type using Fluo4-AM. Peak Ca2+ burst amplitude and duration were decreased in LRRK2-GS–expressing C2 cells compared with LRRK-WT–expressing cells, indicating that SERCA does not function properly in LRRK2-GS–mutated muscle cells (Fig. 7 d-e; Online Resource 7 and 8). Although only a single additional cell type was examined in this study, these results suggest that the effects of LRRK2-GS on ER stress through regulation of SERCA activity is a general phenomenon in certain cell types in which SERCA activity is a prominent feature.
In the current study, we demonstrated that LRRK2-GS acts through SERCA inactivation to trigger ER stress in α-synuclein treated-brain astrocytes, leading to cell death. SERCA is inactivated by its direct interaction with LRRK2-GS, which is translocated to the ER after its release from 14 to 3-3 s. ER-translocated LRRK2-GS persistently maintains the SERCA–PLN complex, thereby disrupting SERCA function and causing ER Ca2+ depletion. Furthermore, LRRK2-GS induced the formation of MAMs and caused Ca2+ overload in mitochondria, leading to mitochondrial dysfunction. Intriguingly, this phenomenon was observed in skeletal muscle cells, another cell type in which SERCA function is prominent.
In most cell types, the ER is the largest intracellular organelle and extends throughout the cytosol. In addition to its role in storing, modifying and transporting newly synthesized proteins, the ER is a high-capacity reservoir for intracellular Ca2+. SERCAs are responsible for maintenance of the micro- to millimolar Ca2+ ion concentrations within the ER of eukaryotic cells. Because ER-resident chaperones like CRT, BiP and GRP94 require high Ca2+ concentrations for their protein-folding activity, the failure of ER Ca2+ homeostasis resulting from SERCA malfunction brings about an imbalance between the capacity of the protein processing machinery and the amount of unfolded proteins accumulated in the ER, leading to ER-stress–mediated apoptosis . Moreover, inappropriate Ca2+ flux from the ER to mitochondria through MAMs impairs several mitochondrial processes. Basal Ca2+ oscillations drive the mitochondrial metabolism necessary for the production of ATP and mitochondrial substrates used in anabolic processes. In contrast, mitochondrial Ca2+ overload can cause cell death . Specifically, this latter study showed that inhibition of SERCA with thapsigargin efficiently killed BAX/BAK−/− mouse embryo fibroblasts (MEFs) by inducing mitochondrial Ca2+ overload and opening of the mPTP . Recent studies have reported that dysregulation of Ca2+ flux through inactivation of SERCA is involved in several neurological diseases, such as Sandhoff disease and Niemann-Pick A disease . Using a neuropathic pain model, Gemes and colleagues found that spinal nerve ligation causes a loss of SERCA that results in depletion of ER Ca2+, and suggested that this may trigger a UPR . These observations highlight the importance of seeking approaches for restoring appropriate regulation of SERCA function in the treatment of various diseases. In the present study, we showed that LRRK2-GS directly binds and regulates SERCA. This LRRK2-GS–SERCA interaction maintains SERCA–PLN interactions, leading to malfunction of SERCA in the ER (Figs. 3 and 4). PLN is profusely expressed in muscle cells and its role in these cells is well known, but the roles and expression patterns of PLN in the brain are largely unknown. One study reported that PLN is not expressed in neurons , whereas another suggested that Mn2+ induced the expression of PLN transcripts in astrocytes . In the current study, we detected PLN expression in both non-Tg and LRRK2-GS astrocytes, but not in neurons (Additional file 2: Figure S5), suggesting that the effect of LRRK2-GS on SERCA may originate from differential expression of PLN. Results obtained in C2 myoblasts further support the idea that this LRRK2-GS mechanism of action is applicable to other cells that express PLN (Fig. 7). Further studies are needed to elucidate whether this is a global or context-specific phenomenon.
The mechanisms that lead to ER dysfunction in PD remain incompletely understood. Moreover, the link between ER dysfunction and PD-related genes, specifically LRRK2, is just starting to be uncovered. Mutated LRRK2 is indirectly involved in ER dysfunction in various ways. First, inhibition of autophagy by mutant LRRK2 might trigger ER dysfunction, given that impairment of autophagy, particularly chaperone-mediated autophagy (CMA), is a reported feature of mutant LRRK2 animal models [35, 61]. Accordingly, impaired autophagy could be a contributing factor to increased α-synuclein aggregation, which initiates aggregated α-synuclein-dependent ER dysfunction, thereby exacerbating the increase in autophagic cargo and further inhibiting CMA. Consequently, LRRK2 mutations further aggravate ER dysfunction. Secondly, perturbation of endosomal trafficking by mutant LRRK2 imposes a burden on ER. LRRK2 has been shown to interact with several Rab family proteins, which are important regulators of intracellular vesicular trafficking. Mutant LRRK2 phosphorylates Rab, probably leading to altered interactions with downstream effectors of Rab, as well as perturbations in endosome-to-lysosome trafficking [26, 59]. That means α-synuclein failed to be degraded by lysosomes in mutant LRRK2, adding further pressure on the ER that ultimately leads to ER dysfunction. Lastly, mitochondrial dysfunction caused by mutant LRRK2 impairs physiological functions of the ER. Mutant LRRK2 induces the expression of Bim, a pro-apoptotic BH3-only family member, by phosphorylating the transcription factor FoxO . Many of these BH3-only proteins affect ER Ca2+ homeostasis by binding to the IP3R and/or changing its phosphorylation status, thereby altering the Ca2+-flux properties of the channel . Moreover, PD-linked LRRK2 mutations increase mitochondrial Ca2+ uptake in cortical neurons in association with increased expression of the mitochondrial Ca2+ uniporter (MCU) . As shown by our MS/MS analysis in the current study, LRRK2-GS also interacts with proteins involved in mitochondria membrane organization and mitochondrial transport, suggesting that LRRK2 may contribute to mitochondria function in astrocytes (Additional file 1: Table S1 Additional file 2: Figure S3). Accordingly, the effect of mutant LRRK2 on mitochondria may induce de novo ER stress or aggravate existing ER dysfunction.
In this study, we demonstrated the molecular mechanism by which G2019S-mutated LRRK2 induces ER stress and subsequent cell death. By incorporating previously unidentified LRRK2-interacting components, this study fills an important gap in our understanding of the relationship between LRRK2-GS and PD pathogenesis. Specifically, our study suggests a plausible model that links LRRK2-GS to pathophysiological ER stress in PD. In addition, novel aspects of this work related to mutated LRRK2 in muscle cells will help shed light on how mutated LRRK2 leads to abnormal phenotypes in peripheral tissues. A better understanding of LRRK2 biology in the context of ER stress could impact ongoing efforts to establish the action mechanism of LRRK2 in both PD and peripheral organs.
In conclusion, we found that LRRK2-GS acts through SERCA inactivation to trigger ER stress in α-synuclein treated-brain astrocytes, leading to cell death. The data showed that SERCA is inactivated by its direct interaction with LRRK2-GS, which is translocated to the ER after its release from 14-3-3s. ER-translocated LRRK2-GS persistently maintains the SERCA–PLN complex, thereby disrupting SERCA function and causing ER Ca2+ depletion. Also, LRRK2-GS induced the formation of MAMs and caused Ca2+ overload in mitochondria, leading to mitochondrial dysfunction. Overall, these data shed light on potential mechanisms underlying LRRK2-GS’s actions in ER stress that renders severe neurological diseases such as PD.
Bhupathy P, Babu GJ, Periasamy M (2007) Sarcolipin and phospholamban as regulators of cardiac sarcoplasmic reticulum Ca2+ ATPase. J Mol Cell Cardiol 42:903–911. https://doi.org/10.1016/j.yjmcc.2007.03.738
Brini M, Carafoli E (2009) Calcium pumps in health and disease. Physiol Rev 89:1341–1378. https://doi.org/10.1152/physrev.00032.2008
Cho HJ, Yu J, Xie C, Rudrabhatla P, Chen X, Wu J, Parisiadou L, Liu G, Sun L, Ma B et al (2014) Leucine-rich repeat kinase 2 regulates Sec16A at ER exit sites to allow ER-Golgi export. EMBO J 33:2314–2331. https://doi.org/10.15252/embj.201487807
Choi YR, Kang SJ, Kim JM, Lee SJ, Jou I, Joe EH, Park SM (2015) FcgammaRIIB mediates the inhibitory effect of aggregated alpha-synuclein on microglial phagocytosis. Neurobiol Dis 83:90–99. https://doi.org/10.1016/j.nbd.2015.08.025
Cooper O, Seo H, Andrabi S, Guardia-Laguarta C, Graziotto J, Sundberg M, McLean JR, Carrillo-Reid L, Xie Z, Osborn T et al (2012) Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson's disease. Sci Transl Med 4:141ra190. https://doi.org/10.1126/scitranslmed.3003985
Dauer W, Przedborski S (2003) Parkinson's disease: mechanisms and models. Neuron 39:889–909
di Domenico A, Carola G, Calatayud C, Pons-Espinal M, Munoz JP, Richaud-Patin Y, Fernandez-Carasa I, Gut M, Faella A, Parameswaran J et al (2019) Patient-specific iPSC-derived astrocytes contribute to non-cell-autonomous neurodegeneration in Parkinson's disease. Stem Cell Reports 12:213–229. https://doi.org/10.1016/j.stemcr.2018.12.011
Dougherty MK, Morrison DK (2004) Unlocking the code of 14-3-3. J Cell Sci 117:1875–1884. https://doi.org/10.1242/jcs.01171
Dzamko N, Deak M, Hentati F, Reith AD, Prescott AR, Alessi DR, Nichols RJ (2010) Inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser(910)/Ser(935), disruption of 14-3-3 binding and altered cytoplasmic localization. Biochem J 430:405–413. https://doi.org/10.1042/BJ20100784
Gehrke S, Imai Y, Sokol N, Lu B (2010) Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression. Nature 466:637–641. https://doi.org/10.1038/nature09191
Gemes G, Rigaud M, Weyker PD, Abram SE, Weihrauch D, Poroli M, Zoga V, Hogan QH (2009) Depletion of calcium stores in injured sensory neurons: anatomic and functional correlates. Anesthesiology 111:393–405. https://doi.org/10.1097/ALN.0b013e3181ae63b0
Greggio E, Jain S, Kingsbury A, Bandopadhyay R, Lewis P, Kaganovich A, van der Brug MP, Beilina A, Blackinton J, Thomas KJ et al (2006) Kinase activity is required for the toxic effects of mutant LRRK2/dardarin. Neurobiol Dis 23:329–341. https://doi.org/10.1016/j.nbd.2006.04.001
Hetz C, Mollereau B (2014) Disturbance of endoplasmic reticulum proteostasis in neurodegenerative diseases. Nat Rev Neurosci 15:233–249. https://doi.org/10.1038/nrn3689
Hsu CH, Chan D, Greggio E, Saha S, Guillily MD, Ferree A, Raghavan K, Shen GC, Segal L, Ryu H et al (2010) MKK6 binds and regulates expression of Parkinson's disease-related protein LRRK2. J Neurochem 112:1593–1604. https://doi.org/10.1111/j.1471-4159.2010.06568.x
Janssen K, Horn S, Niemann MT, Daniel PT, Schulze-Osthoff K, Fischer U (2009) Inhibition of the ER Ca2+ pump forces multidrug-resistant cells deficient in Bak and Bax into necrosis. J Cell Sci 122:4481–4491. https://doi.org/10.1242/jcs.055772
Kanao T, Venderova K, Park DS, Unterman T, Lu B, Imai Y (2010) Activation of FoxO by LRRK2 induces expression of proapoptotic proteins and alters survival of postmitotic dopaminergic neuron in drosophila. Hum Mol Genet 19:3747–3758. https://doi.org/10.1093/hmg/ddq289
Khakh BS, Sofroniew MV (2015) Diversity of astrocyte functions and phenotypes in neural circuits. Nat Neurosci 18:942–952. https://doi.org/10.1038/nn.4043
Ko HS, Bailey R, Smith WW, Liu Z, Shin JH, Lee YI, Zhang YJ, Jiang H, Ross CA, Moore DJ et al (2009) CHIP regulates leucine-rich repeat kinase-2 ubiquitination, degradation, and toxicity. Proc Natl Acad Sci U S A 106:2897–2902. https://doi.org/10.1073/pnas.0810123106
Kwong JQ, Molkentin JD (2015) Physiological and pathological roles of the mitochondrial permeability transition pore in the heart. Cell Metab 21:206–214. https://doi.org/10.1016/j.cmet.2014.12.001
Lee BD, Shin JH, VanKampen J, Petrucelli L, West AB, Ko HS, Lee YI, Maguire-Zeiss KA, Bowers WJ, Federoff HJ et al (2010) Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease. Nat Med 16:998–1000. https://doi.org/10.1038/nm.2199
Li X, Wang QJ, Pan N, Lee S, Zhao Y, Chait BT, Yue Z (2011) Phosphorylation-dependent 14-3-3 binding to LRRK2 is impaired by common mutations of familial Parkinson's disease. PLoS One 6:e17153. https://doi.org/10.1371/journal.pone.0017153
Lim JA, Choi SJ, Moon JY, Kim HS (2016) Alpha-Syntrophin is involved in the survival signaling pathway in myoblasts under menadione-induced oxidative stress. Exp Cell Res 344:1–10. https://doi.org/10.1016/j.yexcr.2016.04.001
Lopez-Crisosto C, Pennanen C, Vasquez-Trincado C, Morales PE, Bravo-Sagua R, Quest AFG, Chiong M, Lavandero S (2017) Sarcoplasmic reticulum-mitochondria communication in cardiovascular pathophysiology. Nat Rev Cardiol 14:342–360. https://doi.org/10.1038/nrcardio.2017.23
Ma Y, Hendershot LM (2004) ER chaperone functions during normal and stress conditions. J Chem Neuroanat 28:51–65. https://doi.org/10.1016/j.jchemneu.2003.08.007
MacLennan DH, Kranias EG (2003) Phospholamban: a crucial regulator of cardiac contractility. Nat Rev Mol Cell Biol 4:566–577. https://doi.org/10.1038/nrm1151
MacLeod DA, Rhinn H, Kuwahara T, Zolin A, Di Paolo G, McCabe BD, Marder KS, Honig LS, Clark LN, Small SA et al (2013) RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson's disease risk. Neuron 77:425–439. https://doi.org/10.1016/j.neuron.2012.11.033
Marino M, Stoilova T, Giorgi C, Bachi A, Cattaneo A, Auricchio A, Pinton P, Zito E (2015) SEPN1, an endoplasmic reticulum-localized selenoprotein linked to skeletal muscle pathology, counteracts hyperoxidation by means of redox-regulating SERCA2 pump activity. Hum Mol Genet 24:1843–1855. https://doi.org/10.1093/hmg/ddu602
Martin I, Dawson VL, Dawson TM (2011) Recent advances in the genetics of Parkinson's disease. Annu Rev Genomics Hum Genet 12:301–325. https://doi.org/10.1146/annurev-genom-082410-101440
Matus S, Glimcher LH, Hetz C (2011) Protein folding stress in neurodegenerative diseases: a glimpse into the ER. Curr Opin Cell Biol 23:239–252. https://doi.org/10.1016/j.ceb.2011.01.003
Mekahli D, Bultynck G, Parys JB, De Smedt H, Missiaen L (2011) Endoplasmic-reticulum calcium depletion and disease. Cold Spring Harb Perspect Biol 3. https://doi.org/10.1101/cshperspect.a004317
Michel PP, Hirsch EC, Hunot S (2016) Understanding dopaminergic cell death pathways in Parkinson disease. Neuron 90:675–691. https://doi.org/10.1016/j.neuron.2016.03.038
Ng CH, Mok SZ, Koh C, Ouyang X, Fivaz ML, Tan EK, Dawson VL, Dawson TM, Yu F, Lim KL (2009) Parkin protects against LRRK2 G2019S mutant-induced dopaminergic neurodegeneration in drosophila. J Neurosci 29:11257–11262. https://doi.org/10.1523/JNEUROSCI.2375-09.2009
Nichols RJ, Dzamko N, Morrice NA, Campbell DG, Deak M, Ordureau A, Macartney T, Tong Y, Shen J, Prescott AR et al (2010) 14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization. Biochem J 430:393–404. https://doi.org/10.1042/BJ20100483
Orchard S, Ammari M, Aranda B, Breuza L, Briganti L, Broackes-Carter F, Campbell NH, Chavali G, Chen C, Del-Toro N et al (2014) The MIntAct project--IntAct as a common curation platform for 11 molecular interaction databases. Nucleic Acids Res 42:D358–D363. https://doi.org/10.1093/nar/gkt1115
Orenstein SJ, Kuo SH, Tasset I, Arias E, Koga H, Fernandez-Carasa I, Cortes E, Honig LS, Dauer W, Consiglio A et al (2013) Interplay of LRRK2 with chaperone-mediated autophagy. Nat Neurosci 16:394–406. https://doi.org/10.1038/nn.3350
Paillusson S, Stoica R, Gomez-Suaga P, Lau DH, Mueller S, Miller T, Miller CC (2016) There's something wrong with my MAM; the ER-mitochondria Axis and neurodegenerative diseases. Trends Neurosci 39:146–157. https://doi.org/10.1016/j.tins.2016.01.008
Paisan-Ruiz C, Jain S, Evans EW, Gilks WP, Simon J, van der Brug M, Lopez de Munain A, Aparicio S, Gil AM, Khan N et al (2004) Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 44:595–600. https://doi.org/10.1016/j.neuron.2004.10.023
Pelled D, Lloyd-Evans E, Riebeling C, Jeyakumar M, Platt FM, Futerman AH (2003) Inhibition of calcium uptake via the sarco/endoplasmic reticulum Ca2+−ATPase in a mouse model of Sandhoff disease and prevention by treatment with N-butyldeoxynojirimycin. J Biol Chem 278:29496–29501. https://doi.org/10.1074/jbc.M302964200
Peng JY, Lin CC, Chen YJ, Kao LS, Liu YC, Chou CC, Huang YH, Chang FR, Wu YC, Tsai YS et al (2011) Automatic morphological subtyping reveals new roles of caspases in mitochondrial dynamics. PLoS Comput Biol 7:e1002212. https://doi.org/10.1371/journal.pcbi.1002212
Plessers L, Eggermont JA, Wuytack F, Casteels R (1991) A study of the organellar Ca2(+)-transport ATPase isozymes in pig cerebellar Purkinje neurons. J Neurosci 11:650–656
Ramonet D, Daher JP, Lin BM, Stafa K, Kim J, Banerjee R, Westerlund M, Pletnikova O, Glauser L, Yang L et al (2011) Dopaminergic neuronal loss, reduced neurite complexity and autophagic abnormalities in transgenic mice expressing G2019S mutant LRRK2. PLoS One 6:e18568. https://doi.org/10.1371/journal.pone.0018568
Raturi A, Gutierrez T, Ortiz-Sandoval C, Ruangkittisakul A, Herrera-Cruz MS, Rockley JP, Gesson K, Ourdev D, Lou PH, Lucchinetti E et al (2016) TMX1 determines cancer cell metabolism as a thiol-based modulator of ER-mitochondria Ca2+ flux. J Cell Biol 214:433–444. https://doi.org/10.1083/jcb.201512077
Raturi A, Simmen T (2013) Where the endoplasmic reticulum and the mitochondrion tie the knot: the mitochondria-associated membrane (MAM). Biochim Biophys Acta 1833:213–224. https://doi.org/10.1016/j.bbamcr.2012.04.013
Richter M, Vidovic N, Honrath B, Mahavadi P, Dodel R, Dolga AM, Culmsee C (2016) Activation of SK2 channels preserves ER ca(2)(+) homeostasis and protects against ER stress-induced cell death. Cell Death Differ 23:814–827. https://doi.org/10.1038/cdd.2015.146
Rizzuto R, De Stefani D, Raffaello A, Mammucari C (2012) Mitochondria as sensors and regulators of calcium signalling. Nat Rev Mol Cell Biol 13:566–578. https://doi.org/10.1038/nrm3412
Roderick HL, Lechleiter JD, Camacho P (2000) Cytosolic phosphorylation of calnexin controls intracellular ca(2+) oscillations via an interaction with SERCA2b. J Cell Biol 149:1235–1248
Rong Y, Distelhorst CW (2008) Bcl-2 protein family members: versatile regulators of calcium signaling in cell survival and apoptosis. Annu Rev Physiol 70:73–91. https://doi.org/10.1146/annurev.physiol.70.021507.105852
Rowland AA, Voeltz GK (2012) Endoplasmic reticulum-mitochondria contacts: function of the junction. Nat Rev Mol Cell Biol 13:607–625. https://doi.org/10.1038/nrm3440
Saha S, Guillily MD, Ferree A, Lanceta J, Chan D, Ghosh J, Hsu CH, Segal L, Raghavan K, Matsumoto K et al (2009) LRRK2 modulates vulnerability to mitochondrial dysfunction in Caenorhabditis elegans. J Neurosci 29:9210–9218. https://doi.org/10.1523/JNEUROSCI.2281-09.2009
Samann J, Hegermann J, von Gromoff E, Eimer S, Baumeister R, Schmidt E (2009) Caenorhabditits elegans LRK-1 and PINK-1 act antagonistically in stress response and neurite outgrowth. J Biol Chem 284:16482–16491. https://doi.org/10.1074/jbc.M808255200
Sancho RM, Law BM, Harvey K (2009) Mutations in the LRRK2 roc-COR tandem domain link Parkinson's disease to Wnt signalling pathways. Hum Mol Genet 18:3955–3968. https://doi.org/10.1093/hmg/ddp337
Sano R, Reed JC (2013) ER stress-induced cell death mechanisms. Biochim Biophys Acta 1833:3460–3470. https://doi.org/10.1016/j.bbamcr.2013.06.028
Schroder M, Kaufman RJ (2005) The mammalian unfolded protein response. Annu Rev Biochem 74:739–789. https://doi.org/10.1146/annurev.biochem.73.011303.074134
Sengupta A, Mense SM, Lan C, Zhou M, Mauro RE, Kellerman L, Bentsman G, Volsky DJ, Louis ED, Graziano JH et al (2007) Gene expression profiling of human primary astrocytes exposed to manganese chloride indicates selective effects on several functions of the cells. Neurotoxicology 28:478–489. https://doi.org/10.1016/j.neuro.2006.10.005
Smith WW, Pei Z, Jiang H, Dawson VL, Dawson TM, Ross CA (2006) Kinase activity of mutant LRRK2 mediates neuronal toxicity. Nat Neurosci 9:1231–1233. https://doi.org/10.1038/nn1776
Sorrentino ZA, Giasson BI, Chakrabarty P (2019) Alpha-Synuclein and astrocytes: tracing the pathways from homeostasis to neurodegeneration in Lewy body disease. Acta Neuropathol. https://doi.org/10.1007/s00401-019-01977-2
Soto C (2012) Transmissible proteins: expanding the prion heresy. Cell 149:968–977. https://doi.org/10.1016/j.cell.2012.05.007
Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) Alpha-synuclein in Lewy bodies. Nature 388:839–840. https://doi.org/10.1038/42166
Steger M, Tonelli F, Ito G, Davies P, Trost M, Vetter M, Wachter S, Lorentzen E, Duddy G, Wilson S et al (2016) Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases. eLife 5. https://doi.org/10.7554/eLife.12813
Szegezdi E, Logue SE, Gorman AM, Samali A (2006) Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Rep 7:880–885. https://doi.org/10.1038/sj.embor.7400779
Tong Y, Yamaguchi H, Giaime E, Boyle S, Kopan R, Kelleher RJ 3rd, Shen J (2010) Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of alpha-synuclein, and apoptotic cell death in aged mice. Proc Natl Acad Sci U S A 107:9879–9884. https://doi.org/10.1073/pnas.1004676107
Vandecaetsbeek I, Vangheluwe P, Raeymaekers L, Wuytack F, Vanoevelen J (2011) The Ca2+ pumps of the endoplasmic reticulum and Golgi apparatus. Cold Spring Harb Perspect Biol 3. https://doi.org/10.1101/cshperspect.a004184
Verma M, Callio J, Otero PA, Sekler I, Wills ZP, Chu CT (2017) Mitochondrial calcium dysregulation contributes to dendrite degeneration mediated by PD/LBD-associated LRRK2 mutants. J Neurosci 37:11151–11165. https://doi.org/10.1523/JNEUROSCI.3791-16.2017
Wieckowski MR, Giorgi C, Lebiedzinska M, Duszynski J, Pinton P (2009) Isolation of mitochondria-associated membranes and mitochondria from animal tissues and cells. Nat Protoc 4:1582–1590. https://doi.org/10.1038/nprot.2009.151
Yuan Y, Cao P, Smith MA, Kramp K, Huang Y, Hisamoto N, Matsumoto K, Hatzoglou M, Jin H, Feng Z (2011) Dysregulated LRRK2 signaling in response to endoplasmic reticulum stress leads to dopaminergic neuron degeneration in C. elegans. PloS one 6: e22354. https://doi.org/10.1371/journal.pone.0022354
Zimprich A, Biskup S, Leitner P, Lichtner P, Farrer M, Lincoln S, Kachergus J, Hulihan M, Uitti RJ, Calne DB et al (2004) Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44:601–607. https://doi.org/10.1016/j.neuron.2004.11.005
This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No.2012R1A5A2048183).
Availability of data materials
The datasets used and/or analyzed during the present study are available from the corresponding author on response request.
Consent of publication
All applicable international, national, and/or institutional guidelines for care and use of animals were followed. All procedures performed in studies involving animals were in accordance with the ethical standards of the institution of practice at which the studies were conducted.
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Table S1. List of LRRK2 interacting proteins, Related Figure 3. (XLSX 41 kb)
Figure S1. The LRRK2-GS mutant induces ER stress and apoptosis in tunicamycin-treated astrocytes. Figure S2. LRRK2-GS is localized to the ER membrane. Figure S3. Analysis of GS-LRRK2–interacting proteins. Figure S4. Identification of GS-LRRK2–interacting proteins. Figure S5. LRRK2-GS promotes SERCA–PLN complex formation. Figure S6. LRRK2 kinase activity does not affect LRRK2 localization. Figure S7. LRRK2-GS astrocytes affect neuronal survival. Table S2. List of siRNA oligonucleotides. Table S3. List of primers used for qPCR. Table S4. List of primary antibodies used in this work. (PDF 5703 kb)
About this article
Cite this article
Lee, J.H., Han, J., Kim, H. et al. Parkinson’s disease-associated LRRK2-G2019S mutant acts through regulation of SERCA activity to control ER stress in astrocytes. acta neuropathol commun 7, 68 (2019). https://doi.org/10.1186/s40478-019-0716-4
- Parkinson’s disease
- ER stress